POST Online Media Lite Edition


Isarna Therapeutics appoints Claus Schalper as CEO

Christian Fernsby |
Muenchen, Germany - Isarna Therapeutics, a clinical stage biotech company, announced the appointment of Claus Schalper as chief executive officer.

Article continues below

Mr. Schalper joins Isarna with over 20 years of experience as an executive and serial entrepreneur in the life science and biotech industries.

Mr. Schalper joins Isarna from Pieris Pharmaceuticals, a company that he cofounded in 2001 and where he held the position of Chief Financial Officer among other roles.

He also cofounded XL protein GmbH.

Mr. Schalper began his career with Arthur Andersen and subsequently served as CEO for several companies in the technology industry.


AEC appoints Alexander Horstmann as new director homologation services
Next.e.GO Mobile appoints Martin C. Klein as new CEO
Next.e.GO Mobile announces new member of its administrative board
Traton appoints Christian Levin as CEO
Castolin Eutectic names Patrick Fetzer as global CEO